Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CureVac N.V (CVAC) Income towards Parent Company: 2018-2024

Historic Income towards Parent Company for CureVac N.V (CVAC) over the last 7 years, with Dec 2024 value amounting to $173.3 million.

  • CureVac N.V's Income towards Parent Company rose 9.27% to -$68.3 million in Q2 2025 from the same period last year, while for Jun 2025 it was $211.7 million, marking a year-over-year increase of 171.34%. This contributed to the annual value of $173.3 million for FY2024, which is 161.91% up from last year.
  • As of FY2024, CureVac N.V's Income towards Parent Company stood at $173.3 million, which was up 161.91% from -$279.9 million recorded in FY2023.
  • In the past 5 years, CureVac N.V's Income towards Parent Company ranged from a high of $173.3 million in FY2024 and a low of -$471.0 million during FY2021.
  • In the last 3 years, CureVac N.V's Income towards Parent Company had a median value of -$254.1 million in 2022 and averaged -$120.2 million.
  • In the last 5 years, CureVac N.V's Income towards Parent Company slumped by 205.94% in 2021 and then surged by 161.91% in 2024.
  • Over the past 5 years, CureVac N.V's Income towards Parent Company (Yearly) stood at -$154.0 million in 2020, then slumped by 205.94% to -$471.0 million in 2021, then skyrocketed by 46.06% to -$254.1 million in 2022, then dropped by 10.18% to -$279.9 million in 2023, then spiked by 161.91% to $173.3 million in 2024.